Chronic pelvic pain is a syndrome, not one diagnosis
ACOG describes chronic pelvic pain as pelvic-area pain lasting six months or longer that can disrupt activity, work, sleep, relationships and mental health. [1] It may be constant, cyclical or triggered by urination, bowel movements, eating, sex, movement or posture. More than one contributor is common, and sometimes no single tissue lesion explains the burden.
Potential contributors include endometriosis, adenomyosis, fibroids, painful bladder syndrome, irritable bowel syndrome, pelvic-floor myofascial pain, vulvodynia, nerve injury and musculoskeletal conditions. Central pain amplification can persist after an initial injury. Naming this process validates pain and broadens treatment; it does not mean the pain is imagined.
- Map cycle, bladder, bowel, sexual and movement triggers.
- Describe function as well as intensity.
- Record prior surgery and treatment response.
- Expect overlap rather than insisting on one cause.
Urgent and progressive conditions still need exclusion
Chronicity does not protect against an acute problem. Pregnancy possibility, sudden severe pain, fever, heavy bleeding, fainting, persistent vomiting or acute abdominal signs require urgent assessment. New postmenopausal bleeding, a mass, unexplained weight loss, blood in urine or stool and progressive neurological symptoms require targeted evaluation.
Tests should follow the history and examination rather than a standard battery. Ultrasound can assess pelvic anatomy, while laboratory, gastrointestinal, urological or neurological investigations are selected for specific findings. ACOG notes that specialists may include gynecology, gastroenterology, urogynecology, pelvic physiotherapy, pain medicine and mental health. [1]
- Check pregnancy status when clinically relevant.
- Escalate acute systemic or bleeding symptoms.
- Use imaging to answer a defined question.
- Reassess when the pain pattern changes.
Examination should include muscles and nerves, not pelvic organs alone
Pelvic-floor tenderness and trigger points are common in chronic pelvic pain. Abdominal wall, hip, back and nerve examination can identify pain generators outside internal pelvic organs. ACOG's bulletin emphasizes the complex, multidisciplinary nature of evaluation. [2] The patient should control whether and how an internal examination proceeds.
A pain and activity diary can reveal patterns, but excessively detailed monitoring can be burdensome. Validated measures of pain interference, sleep, mood and function may be more useful than repeated maximum pain scores. Trauma history can be relevant, yet physical causes must still be considered and disclosure should never be forced.
- Assess abdominal wall and pelvic-floor tenderness.
- Check hip, spine and movement when indicated.
- Use consent-based internal examination.
- Choose measures that will change the plan.
Treatment works best as a coordinated portfolio
Identified conditions should receive condition-specific treatment, while shared pain mechanisms may need parallel care. Pelvic-floor physical therapy can address myofascial pain and desensitization. Cognitive behavioral therapy, acceptance-based care, sex therapy and mindfulness can improve coping, function and self-efficacy without denying biological pain. The 2024 Canadian guideline supports multimodal pelvic physiotherapy and psychological approaches. [6]
Medication should match a mechanism and include a review point. Anti-inflammatory medicines can help dysmenorrhea; hormonal suppression may help cyclic gynecologic pain; and selected neuropathic-pain medicines may be considered. Opioids have limited roles in chronic noncancer pain and require careful risk assessment. Sleep, constipation, activity pacing and social support can materially affect function.
- Treat identified disease and pain amplification together.
- Use physical therapy for documented myofascial contributors.
- Set a goal and stop rule for every medicine.
- Coordinate rather than serially repeating disconnected referrals.
More intervention is not always better
Repeated surgery for nonspecific pain can add adhesions and new pain without addressing bladder, bowel, muscular or central contributors. Surgery should target a supported diagnosis and include realistic benefit, fertility impact and recurrence discussion. A hysterectomy does not treat pain generated outside the uterus and is not a universal endpoint.
The large GaPP2 randomized trial found that gabapentin did not significantly improve chronic pelvic pain without obvious pelvic pathology and produced more serious adverse events than placebo. [5] This result illustrates why off-label prescribing still needs trial evidence, adverse-effect monitoring and discontinuation when benefit is absent.
- Name the suspected pain generator before surgery.
- Review prior procedures and their actual effect.
- Do not continue sedating medicine without functional benefit.
- Include fertility and sexual outcomes in procedural consent.
Success is improved life, even when pain is not zero
A plan may target fewer flares, better sleep, comfortable sitting, return to work, chosen sexual activity, exercise or reduced urgent-care use. Pain intensity remains relevant, but a narrow zero-pain target can obscure meaningful recovery. The patient should identify the functions that matter most and the tradeoffs they will accept. [1][2][3]
Care quality includes one coordinating clinician, shared records and periodic diagnostic review. New evidence or a changed pattern may justify renewed investigation, while stable symptoms may benefit more from rehabilitation than another scan. Chronic pelvic pain deserves the same rigor as other chronic pain: validation, red-flag vigilance, mechanism-based treatment and sustained partnership. [1][2][6]
- Use patient-selected functional goals.
- Track mood and sleep as outcomes, not explanations.
- Name the clinician coordinating the plan.
- Review diagnosis and treatment burden at agreed intervals.
What the evidence cannot yet answer
- Prevalence estimates vary with pain definition, population and study quality, with sparse data from many regions.
- Many treatments are studied in small, mixed populations and effects may not transfer across pain mechanisms.
- Finding a lesion does not prove it is the sole cause of pain.
- Improvement may require combined care, making the contribution of one component difficult to isolate.
Questions worth taking into care
- Which gynecologic, bladder, bowel, muscle and nerve contributors have been assessed?
- Are there red flags or a changed pattern requiring new investigation?
- What mechanism and goal justify each medicine or procedure?
- Who is coordinating my multidisciplinary plan?
- Which daily-life outcomes will define worthwhile improvement?
Source record
Evidence used in this review
Sources were selected for clinical authority, methodological relevance and traceability. Links open the original guidance, public-health record or research publication.
- [1]Chronic Pelvic Pain
American College of Obstetricians and Gynecologists · 2025
- [2]Chronic Pelvic Pain: ACOG Practice Bulletin No. 218
American College of Obstetricians and Gynecologists · 2020
- [3]Chronic Pelvic Pain in Women: A Review
JAMA · 2021
- [4]WHO Systematic Review of Prevalence of Chronic Pelvic Pain
BMC Public Health · 2006
- [5]Gabapentin for Chronic Pelvic Pain in Women: GaPP2 Trial
The Lancet · 2020
- [6]Guideline No. 445: Management of Chronic Pelvic Pain
Society of Obstetricians and Gynaecologists of Canada · 2024
This evidence synthesis is for general information. It does not diagnose a condition or replace care from a qualified health professional. Treatment choices depend on individual history, examination, local guidance and informed preference. Emergency or rapidly worsening symptoms need urgent local medical assessment.



